Portfolio company
Verge
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides a technology platform using artificial intelligence and human genomics to discover and develop drugs for patients with neurodegenerative diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Verge Genomics
This company develops neurodegenerative disease treatments for pharmaceutical partners and patients using an artificial intelligence platform trained on proprietary human genomic datasets.
CoSyne Therapeutics
The company develops artificial intelligence platforms to discover precision medicines for patients with brain cancer and neurological conditions.
Vimana
This stealth-mode healthcare company develops a multimodal generative artificial intelligence platform to create precision diagnostics and therapies for neurological disorders.
Exin Therapeutics
This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
Pangea Botanica
This company develops medicines for neurological and mental health disorders using an artificial intelligence platform to discover neuroactive molecules from medicinal plants.
Nerai
This company develops specific genome editors using an artificial intelligence protein discovery platform for biotechnology firms and patients with rare inherited diseases.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
